Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P9MQ
|
||||
| Former ID |
DNC014461
|
||||
| Drug Name |
(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531163] | ||
| Formula |
C21H24N2O4
|
||||
| Canonical SMILES |
COC(=O)C(C1CCCCN1CC2=CC=C(C=C2)[N+](=O)[O-])C3=CC=CC=C3
|
||||
| InChI |
1S/C21H24N2O4/c1-27-21(24)20(17-7-3-2-4-8-17)19-9-5-6-14-22(19)15-16-10-12-18(13-11-16)23(25)26/h2-4,7-8,10-13,19-20H,5-6,9,14-15H2,1H3/t19-,20-/m1/s1
|
||||
| InChIKey |
WXZFAWFIMBPTEP-WOJBJXKFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent dopamine transporter | Target Info | Inhibitor | [531163] | |
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.